Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroendocrine Tumors 1 Gastro-enteropancreatic neuroendocrine tumor 1 Chemoprevention 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Chemoprevention × Resveratrol × Clear all

NCT04266353 2023-05-09

Effect of Resveratrol on Serum IGF2 Among African American Women

Loma Linda University

Phase NA Withdrawn

Chemoprevention

Data powered by HemOnc (CC BY 4.0) Colophon ⚡